As one of the exhibitor at EndoBolism-2011, the exhibitors can present your services and products to a motivated and well-informed professionals public from all over the world. Here you can talk directly to experts who can apply your services or have a special interest in using your products. The delegates attending EndoBolism-2011 is mainly senior scientists, directly responsible for development of research program, specifying and purchasing laboratory diagnostics, medical advices and equipments. In short, they are your present and new customers.
Exhibitors' advantages
The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.
Xiamen
Renowned Speaker
Dr. Jan-Ake Gustafsson, Professor, Department of Biosciences & Nutrition, University of Houston, USA
Dr. Mark Powell, Senior Vice President and Worldwide Head-Pharmaceutical Development, Bristol Myers Squibb Co., Ltd., USA
Dr. Michael R. Hanley, Chief Scientific Officer, Amylin Pharmaceuticals, Inc., USA
Dr. Nancy E. Lane, Director and Distinguished Professor, UC Davis Center for Healthy Aging, USA
Dr. Xiaoling Li, Principal Investigator, Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, USA
Dr. John A. Cidlowski, Head of the Molecular Endocrinology Group within the LST, National Institutes of Environmental Health Sciences, USA
Dr. Erin Pias Hines, Biologist, US Environmental Protection Agency, USA
Dr. Jean-Patrice Baillargeon, Director of Endocrinology Metabolism, University of Sherbrooke, Canada
Dr. Xavier Bonnefont, Professor, The Institute of Functional Genomics, CNRS, France
Dr. Nader Rahnama, Professor of Sport Medicine, Florida State University, USA
Dr. Christopher Wilcox, Director, Center for Hypertension, Kidney and Vascular Health, Georgetown University, USA
Dr. Eugenio Cersosimo, Medical Director of Clinical Research, Texas Diabetes Institute, University of Texas, USA
Dr. Ming Wang, Director of Metabolism Group, Amgen Inc., USA
Dr. Enrico Carmina, Executive Director of Androgen Excess and PCOS Society, Head of Endocrine Unit, University of Palermo, Italy
Dr. Alan Maisel, Principal Investigator, UCSD, San Diego VA Hospital, USA
Dr. Serge CARREAU, Director Research CNRS, Université de Caen Basse-Normandie, France
Dr. William B Inabnet, Director of Surgical Sciences, Metabolic Institute, Mount Sinai Medical Center, USA
Dr. Dace L.Trence, Director, Diabetes Care Center, University of Washington Medical Center, USA
Dr. Bradford Therrell, Professor, The Department of Pediatrics at the University of Texas Health Science Center at San Antonio, USA
Dr. Hadas Stiebel-Kalish, Chief, Neuro-Ophthalmology, Rabin Medical Center, Israel
Dr. Zhaohui Ni, Director, Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine, China
Dr. Gwen V. Childs, Professor and Chair, Department of Neurobiology and Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, USA
Dr. Matthias Bureik, CEO, Chemist, Co-Founder, PomBioTech, Germany
Dr. Russel J. Reiter, Professor, Department of Cellular and Structural Biology, University of Texas Health Science Center, USA
